Ivabradine Hydrochloride
Who holds supplier records for Ivabradine Hydrochloride? 10 organisations hold a current record for Ivabradine Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4), China (2) and France (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Ivabradine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/ivabradine-hydrochloride
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ivabradine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 32074 · latest filing Sept 2017
- BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTDChinaActive DMF 28658 · latest filing Sept 2014
- BionpharmaActive DMF 33077 · latest filing Sept 2018
- FUXIN LONG RUI PHARMACEUTICAL CO LTDActive DMF 33377 · latest filing Dec 2018
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 33368 · latest filing Dec 2018
- Maithri Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 33246 · latest filing Oct 2018
- ORIL INDUSTRIEFranceActive DMF 27979 · latest filing Mar 2014
- URQUIMA SACompany GMP cert on recordActive DMF 33213 · latest filing Oct 2018
- Zhejiang Liaoyuan Pharmaceutical Co., Ltd.ChinaActive DMF 32616 · latest filing Oct 2019
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 33107 · latest filing Oct 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ivabradine Hydrochloride is a heart rate-reducing medication used in the treatment of chronic heart failure and angina by selectively inhibiting the cardiac pacemaker If current. It functions by slowing the heart rate thereby reducing the heart's oxygen demand and improving blood flow.
Chemical identity
- IUPAC name
- 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;hydrochloride
- Canonical SMILES
- CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)C[C@H]3CC4=CC(=C(C=C34)OC)OC.Cl
- InChIKey
- HLUKNZUABFFNQS-ZMBIFBSDSA-N
- Synonyms
- Corlanor API, amg 998, amg-998, corlanor, corlentor, ivabradine hcl, procoralan, s-16257-2
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
- Mechanism of action
- Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ivabradine Hydrochloride?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Ivabradine Hydrochloride: Alembic Pharmaceuticals Limited (India), BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD (China), Bionpharma, FUXIN LONG RUI PHARMACEUTICAL CO LTD, Hetero Drugs Limited (India), Maithri Laboratories Private Limited (India), ORIL INDUSTRIE (France) and URQUIMA SA, and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ivabradine Hydrochloride Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 32074), BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD (DMF 28658), Bionpharma (DMF 33077), FUXIN LONG RUI PHARMACEUTICAL CO LTD (DMF 33377), Hetero Drugs Limited (DMF 33368), Maithri Laboratories Private Limited (DMF 33246), ORIL INDUSTRIE (DMF 27979) and URQUIMA SA (DMF 33213) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Ivabradine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ivabradine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.